Target intelligence / Profile preview

Muscle function

01

Overview

Muscle function is a broad physiological term describing the integrated capability of skeletal, cardiac, and smooth muscle tissues to generate force and perform mechanical work through contraction and relaxation cycles (6, 9). It is not a discrete molecular target, such as a specific receptor or enzyme; rather, it represents a complex phenotypic outcome resulting from the coordinated activity of structural proteins (e.g., myosin, actin), regulatory proteins (e.g., troponin, tropomyosin), and ion channels (e.g., ryanodine receptors) (1, 6). In drug discovery and clinical research, muscle function often serves as a primary endpoint or therapeutic goal for evaluating the efficacy of interventions for conditions like sarcopenia, Duchenne muscular dystrophy, and cancer-induced cachexia (2, 14). While various drugs are developed to enhance muscle performance by targeting specific molecular components—such as myostatin inhibitors (e.g., PF-354) or ryanodine receptor stabilizers (Rycals)—the term 'muscle function' itself refers to a biological process rather than a single targetable molecule (4, 10, 11). Consequently, it is classified as an incorrect entry for structured molecular target databases because it lacks a unique biochemical structure or direct drug-binding site (13). For precise target annotation, a specific molecular entity involved in this process, such as a signaling receptor or contractile protein, must be identified instead (2, 8).

Other names
Muscle performanceMuscle strengthContractile activityMotor function
02

Mechanism of action

Not applicable; muscle function is a physiological process/endpoint rather than a specific molecular target with a mechanism of action.

03

Biological functions

Muscle contractionLocomotionThermogenesisMaintenance of postureBody heat production
04

Disease associations

SarcopeniaMuscular dystrophyCachexiaMyasthenia gravisAmyotrophic lateral sclerosisMyopathy
05

Safety considerations

Off-target effects on non-skeletal muscle tissues (cardiac or smooth muscle) if systemic regulators are targetedRisk of metabolic or electrolyte imbalances when modulating muscle signaling pathwaysPotential for maladaptive hypertrophy if growth-regulatory pathways are non-selectively activated
06

Biomarkers

Handgrip strength6-minute walk test (6MWT)Short Physical Performance Battery (SPPB) scoreTimed Up and Go (TUG) testSerum creatine kinase (CK) levelsSkeletal muscle mass index (SMI)

Beyond the preview

Go deeper on Muscle function.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Muscle function.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call